BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9087680)

  • 21. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide.
    Shultz PJ; Tolins JP
    J Clin Invest; 1993 Feb; 91(2):642-50. PubMed ID: 7679414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiovascular and renal effects of acute and chronic inhibition of nitric oxide production in fetal sheep.
    Yu ZY; Lumbers ER; Simonetta G
    Exp Physiol; 2002 May; 87(3):343-51. PubMed ID: 12089602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid nongenomic effects of aldosterone on the renal vasculature in humans.
    Schmidt BM; Sammer U; Fleischmann I; Schlaich M; Delles C; Schmieder RE
    Hypertension; 2006 Apr; 47(4):650-5. PubMed ID: 16520409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of endothelium-derived nitric oxide on renal hemodynamics and function in the sheep fetus.
    Bogaert GA; Kogan BA; Mevorach RA
    Pediatr Res; 1993 Dec; 34(6):755-61. PubMed ID: 8108188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs.
    Manning RD; Hu L
    Hypertension; 1994 May; 23(5):619-25. PubMed ID: 8175171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide.
    Salazar FJ; Pinilla JM; López F; Romero JC; Quesada T
    Hypertension; 1992 Jul; 20(1):113-7. PubMed ID: 1618546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration.
    King AJ; Troy JL; Anderson S; Neuringer JR; Gunning M; Brenner BM
    J Am Soc Nephrol; 1991 Jun; 1(12):1271-7. PubMed ID: 1912389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactive control of renal function by alpha 2-adrenergic system and nitric oxide: role of angiotensin II.
    Vallon V; Peterson OW; Gabbai FB; Blantz RC; Thomson SC
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):916-22. PubMed ID: 8606528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects.
    Al Therwani S; Rosenbæk JB; Mose FH; Bech JN; Pedersen EB
    BMC Nephrol; 2017 Mar; 18(1):86. PubMed ID: 28288570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.
    Haynes WG; Noon JP; Walker BR; Webb DJ
    J Hypertens; 1993 Dec; 11(12):1375-80. PubMed ID: 7510736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
    Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
    Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock.
    Lieberthal W; McGarry AE; Sheils J; Valeri CR
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F868-72. PubMed ID: 1951718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
    Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P
    Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
    Larsen T; Mose FH; Bech JN; Pedersen EB
    Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.
    Venkatakrishnan U; Chen C; Lokhandwala MF
    Clin Exp Hypertens; 2000 Apr; 22(3):309-24. PubMed ID: 10803736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of endogenous nitric oxide production results in moderate hypertension, reducing sympathetic activity and shortening bleeding time in healthy volunteers.
    Albert J; Schedin U; Lindqvist M; Melcher A; Hjemdahl P; Frostell C
    Acta Anaesthesiol Scand; 1997 Oct; 41(9):1104-13. PubMed ID: 9366930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.